)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Moberg Pharma
Moberg Pharma (MOB) investor relations material
Moberg Pharma Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary17 Feb, 2026
Product overview and differentiation
TerclaraⓇ is a novel topical terbinafine treatment for mild to moderate nail fungus in adults, approved in 13 European countries.
Delivers terbinafine directly to the nail, achieving 1000x higher concentration in the nail and 40x in the nail bed compared to oral treatment, with negligible systemic absorption.
Achieves a best-in-class mycological cure rate of 76%, matching oral terbinafine and outperforming other topical competitors.
Offers rapid visible improvement, easy application, and a favorable safety profile with no risk of systemic side effects.
Features differentiated packaging and does not require nail filing or lacquer removal.
Market position and commercial performance
Achieved market leadership in Sweden and Norway, driving category growth and increasing market share significantly in both countries.
Awarded 'Launch of the Year 2024' in Sweden and nominated for the same in Norway, recognized for innovation and strong sales.
Holds a strong premium position due to superior cure rates, supporting higher pricing compared to competitors.
Partners with Karo for EU distribution (excluding Sweden and Norway), covering 19 countries and reaching 500 million citizens.
Commercial success builds on proven models and previous launches, such as Kerasal Nail® in the US.
Clinical evidence and regulatory status
Supported by two Phase 3 studies (over 800 patients) meeting primary endpoints, demonstrating high cure rates and safety.
Approved as an OTC or Rx product in major European markets, with additional approvals pending.
Global patent protection until 2032, with ongoing applications.
Terclara's complete cure rate vs. competitors
Karo's strategy for Terclara and Lamisil brands
Terclara's US market entry timeline and strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Moberg Pharma earnings date
Q1 202612 May, 2026
Moberg Pharma
Next Moberg Pharma earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Moberg Pharma AB develops, manufactures and markets OTC products in the areas of footcare and oral healthcare. The company own the rights to a patented platform technology, which means that they can tailor each product exactly to the needs of each customer. The products are primarily sold through intermediaries and are developed in close collaboration with leading retailers, who sell them on their home markets. Moberg Pharma AB market some of their products directly under their own brands, or via the company's own sales force on a limited number of selected markets.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage